RT @Yuz6Yusof: Results are out. The majority would use #anifrolumab to treat refractory skin and joints disease #SLE. Th
Tweet Content
Results are out. The majority would use #anifrolumab to treat refractory skin and joints disease #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/wguBCkhZ7B
Show on Archive Page
On
Display in Search Results
On
PDQ
Off